GPT and metabolic dysfunction-associated steatohepatitis: In NASH mouse models, SS-A1 and SS-Bb alleviate steatohepatitis and fibrosis, reduce serum ALT, AST, and LPS levels, and decrease hepatic TNF-α, IL-6, TG, and cholesterol content.